AMERISAFE, Inc.
NASDAQ:AMSFInsurance - Specialty
+$0.25 today
- Market cap
- $350.83M
- Beta
- 0.28
- P/E (TTM)
- 12.7
- EPS (TTM)
- $2.47
- Dividend yield
- 8.26%
Volume 0.40M
Average 0.23M
AMSF Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
AMERISAFE, Inc.NASDAQ: AMSF
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How AMSF compares with its peers on the latest reported figures
- AMSF's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for AMSF, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AMSF) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for AMSF. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 316.01M | 294.69M | 306.91M | 309.11M | 317.25M |
| Cost of Revenue | 160.8M | 152.32M | 171.71M | 181.02M | 169.94M |
| Gross Profit | 155.22M | 142.38M | 135.2M | 128.09M | 147.32M |
| Gross Margin | 49.1% | 48.3% | 44.1% | 41.4% | 46.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 25.95M | 26.51M | 27.36M | 31.5M | 0 |
| Operating Expenses | 75.77M | 74.73M | 57.82M | 59.04M | 88.46M |
| Depreciation & Amortization | 1.02M | 1.31M | 1.43M | 1.09M | 742K |
| EBITDA | 80.47M | 68.96M | 0 | 70.15M | 59.59M |
| EBITDA Margin | 25.5% | 23.4% | 0.0% | 22.7% | 18.8% |
| Operating Income | 79.45M | 67.65M | 77.38M | 69.06M | 58.85M |
| Operating Margin | 25.1% | 23.0% | 25.2% | 22.3% | 18.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 79.45M | 67.65M | 77.38M | 69.06M | 58.85M |
| Pre-Tax Margin | 25.1% | 23.0% | 25.2% | 22.3% | 18.6% |
| Income Tax Expense | 13.69M | 12.04M | 15.27M | 13.62M | 11.71M |
| Net Income | 65.76M | 55.6M | 62.11M | 55.44M | 47.15M |
| Net Margin | 20.8% | 18.9% | 20.2% | 17.9% | 14.9% |
| EPS (Basic) | 3.40 | 2.89 | 3.24 | 2.91 | 2.48 |
| EPS (Diluted) | 3.39 | 2.88 | 3.23 | 2.89 | 2.47 |
| Weighted Avg Shares | 19.33M | 19.23M | 19.15M | 19.07M | 18.98M |
| Weighted Avg Shares (Diluted) | 19.41M | 19.32M | 19.23M | 19.16M | 19.08M |
AMERISAFE, Inc.
NASDAQ:AMSF
Intrinsic Alpha fair value
Locked
Current Price
$18.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.